dendritic cell vaccination

You have access
Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial
KAZUHIRO NAGAI, TOMOHIKO ADACHI, HIROSHI HARADA, SUSUMU EGUCHI, HARUO SUGIYAMA and YASUSHI MIYAZAKI

Anticancer Research October 2020, 40 (10) 5765-5776; DOI: https://doi.org/10.21873/anticanres.14593
You have access
Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy
MARKOS ANTONOPOULOS, STEFAAN W. VAN GOOL, DIMITRA DIONYSIOU, NORBERT GRAF and GEORGIOS STAMATAKOS

Anticancer Research April 2019, 39 (4) 2043-2051; DOI: https://doi.org/10.21873/anticanres.13315

Main menu